Document Type : Research articles

Authors

1 M.D, Assistant Professor, Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

2 Ph.D, Assistant Professor, Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

3 M.D, Associate Professor, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine and Shiraz Regional Educational Blood Transfusion Center, Shiraz, Iran

4 Medical Student, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

5 M.D. MPH, Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

6 M.D, Distinguished Professor, Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background: Although blood is donated rather than purchased, collecting, storing, and testing it for viral markers is expensive. During the Cost of Blood Consensus Conference (COBCON), activity-based costing (ABC) was proposed as a standard way to figure out the cost of preparing a unit of blood.
Objectives: The ABC can be used by any organization that pays for blood or blood products. It was used to determine how much each unit of allogeneic blood costs in Iran, considering the limited blood sources and the importance of cost evaluation studies.
Methods: This cross-sectional, descriptive-analytical study was conducted at Shiraz Blood Transfusion Organization in 2020-2021 (Shiraz, Iran). We used the ABC method to determine how much each unit of allogeneic blood costs in Iran. In this study, activity centers were divided into high-level, intermediate, and final activity centers. The resources of each activity center were made up of human resources, consumables, buildings, equipment, and energy.
Results: Direct and indirect costs of producing blood were separately investigated in the studied sub-units. The final estimated cost of preparing one blood unit was almost 13 million IRR (?308 USD). According to our findings, indirect costs comprised a significant portion (86.45%) of the cost of producing a unit of blood, while direct costs accounted for only 13.55%.
Conclusion: As evidenced by the obtained results, the cost of one blood unit was far more than the national average estimated by the Iran Blood Transfusion Organization. There is a need for additional research on the cost of other blood products and indirect cost reduction strategies.

Keywords

  1. Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol. 2013;27(1):59-68. doi: 10.1016/j.bpa.2013.02.001. [PubMed: 23590916].
  2. Tinegate H, Chattree S, Iqbal A, Plews D, Whitehead J, Wallis JP, et al. Ten‐year pattern of red blood cell use in the North of England. Transfusion. 2013;53(3):483-9. doi: 10.1111/j.1537-2995.2012.03782.x. [PubMed: 22803573]
  3. Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg.2007;83(5):27-86. doi:10.1016/j.athoracsur.2007.02.099. [PubMed: 17462454].
  4. Forbes JM, Anderson MD, Anderson GF, Bleecker GC, Rossi EC, Moss GS. Blood transfusion costs: a multicenter study. Transfusion. 1991;31(4):318-23. doi: 10.1046/j.1537-2995.1991.31491213295.x. [PubMed: 2020994].
  5. Lubarsky DA, Hahn C, Bennett DH, Smith LR, Bredehoeft SJ, Klein HG, et al. The hospital cost (fiscal year 1991/1992) of a simple perioperative allogeneic red blood cell transfusion during elective surgery at Duke University. Anesth Analg. 1994;79(4):629-37. doi: 10.1213/00000539-199410000-00003. [PubMed: 7943767].
  6. Roberts WA, Kirkley SA, Newby M. A cost comparison of allogeneic and preoperatively or intraoperatively donated autologous blood. Anesth Analg. 1996;83(1):129-33. doi: 10.1097/00000539-199607000-00023. [PubMed: 8659723].
  7. Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion. 2012;52(9):1983-8. doi: 10.1111/j.1537-2995.2011.03532.x. [PubMed: 22313531].
  8. Aledort L, Broder M, Busch M, Custer B, Fergusson D, Goodnough L, et al. The cost of blood: multidisciplinary consensus conference for a standard methodology. Transfus Med Rev. 2005;19(1):66-78. doi: 10.1016/j.tmrv.2004.09.005. [PubMed: 15830329].
  9. Ruiz J, Dugan A, Davenport DL, Gedaly R. Blood transfusion is a critical determinant of resource utilization and total hospital cost in liver transplantation. Clin Transplant. 2018;32(2). doi: 10.1111/ctr.13164. [PubMed: 29193383].
  10. Sun D, Abraham I. The cost of allogeneic blood transfusion. World J Hematol. 2012;1(3):8-13. doi: 10.5315/wjh.v1.i3.8.
  11. Davoudi-Kiakalayeh A, Paridar M, Toogeh G. Cost unit analysis of blood transfusion centers in Guilan province. Sci J Iran Blood Transfus Organ. 2012;9(3):346-52.
  12. Gharehbaghian A, Jalilzadeh Khoei M, Honarkaran N, Davoodi F. Estimsation and comparison of the production cost of blood and blood products in 28 IBTO centers in 2002. Sci J Iran Blood Transfus Organ. 2005;1(2):61-70.
  13. İndelen C, Uygun Kızmaz Y, Kar A, Shander A, Kırali K. The cost of one unit blood transfusion components and cost-effectiveness analysis results of transfusion improvement program. Turk Gogus Kalp Damar Cerrahisi Derg. 2021;29(2):150-7. doi: 10.5606/tgkdc.dergisi.2021.20886. [PubMed: 34104508].
  14. Wang D, Ye Y, Zheng Q. Cost of blood and body fluid occupational exposure management in Beijing, China. Int J Environ Res Public Health. 2020;17(12):4192. doi: 10.3390/ijerph17124192. [PubMed: 32545465].
  15. Cantor SB, Hudson Jr DV, Lichtiger B, Rubenstein EB. Costs of blood transfusion: a process-flow analysis. J Clin Oncol. 1998;16(7):2364-70. doi: 10.1200/JCO.1998.16.7.2364. [PubMed: 9667252].
  16. Cremieux P-Y, Barrett B, Anderson K, Slavin MB. Cost of outpatient blood transfusion in cancer patients. J Clin Oncol. 2000;18(14):2755-61. doi: 10.1200/JCO.2000.18.14.2755. [PubMed: 10894876].
  17. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity‐based costs of blood transfusions
  18. in surgical patients at four hospitals. Transfusion. 2010;50(4):753-65. doi: 10.1111/j.1537-2995.2009.02518.x. [PubMed: 20003061].
  19. Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol. 2007;21(2):271-89. doi: 10.1016/j.bpa.2007.01.002. [PubMed: 17650777].